Corient Private Wealth
DXCM icon

Corient Private Wealth’s DexCom DXCM Stock Holding History

Corient Private Wealth’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81M Buy
130,738
+3,986
+3% +$266K 0.01% 685
2026
Q1 		$8.01M Buy
126,752
+2,998
+2% +$209K 0.01% 694
2025
Q4 		$8.22M Buy
123,754
+87,468
+241% +$5.65M 0.01% 610
2025
Q3 		$2.44M Sell
36,286
-85,838
-70% -$6.79M ﹤0.01% 978
2025
Q2 		$10.7M Buy
122,124
+1,433
+1% +$112K 0.01% 517
2025
Q1 		$8.24M Sell
120,691
-6,688
-5% -$546K 0.01% 558
2024
Q4 		$9.91M Sell
127,379
-2,402
-2% -$178K 0.02% 517
2024
Q3 		$8.7M Sell
129,781
-20,530
-14% -$1.69M 0.01% 599
2024
Q2 		$17M Buy
150,311
+3,403
+2% +$430K 0.03% 418
2024
Q1 		$20.4M Sell
146,908
-16,205
-10% -$2.04M 0.04% 386
2023
Q4 		$20.2M Buy
163,113
+13,132
+9% +$1.34M 0.04% 384
2023
Q3 		$14.4M Sell
149,981
-4,909
-3% -$553K 0.03% 413
2023
Q2 		$19.9M Buy
154,890
+4,844
+3% +$586K 0.05% 341
2023
Q1 		$17.4M Buy
150,046
+4,550
+3% +$509K 0.05% 341
2022
Q4 		$16.5M Buy
+145,496
New +$16M 0.06% 294

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Corient Private Wealth's DXCM Position: Q2 2026 in Review

Corient Private Wealth increased its DexCom (DXCM) stake by 3.1% in Q2 2026, buying an estimated $266K and bringing the position to 130,738 shares worth $8.81M. The position accounts for 0.01% of the portfolio, ranked #685.

Corient Private Wealth first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. The position peaked at $20.4M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Corient Private Wealth held 130,738 shares of DexCom worth $8.81M as of Q2 2026.
  • Corient Private Wealth bought 3,986 DexCom shares in Q2 2026, an estimated $266K.
  • DexCom made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #685 holding.
  • Corient Private Wealth first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's DexCom position peaked at $20.4M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.